Chemoprophylaxis in malaria: Drugs, evidence of efficacy and costs

Asian Pacific Journal of Tropical Medicine

Volumn 4, Issue 4, 2011, Pages 330-336

  Fernando, Sumadhya Deepika ^a   Rodrigo, Chaturaka ^b   Rajapakse, Senaka ^a  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

^b NATIONAL HOSPITAL OF SRI LANKA   (Sri Lanka)

Author keywords

Cost; Malaria; Pregnancy; Prophylaxis

Indexed keywords

ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; AZITHROMYCIN; CHLOROQUINE; CHLOROQUINE PLUS PRIMAQUINE; CHLOROQUINE PLUS PROGUANIL; COTRIMOXAZOLE; DOXYCYCLINE; DOXYCYCLINE HYCLATE; MEFLOQUINE; PLACEBO; PRIMAQUINE; PROGUANIL; PYRIMETHAMINE PLUS SULFADOXINE; TETRACYCLINE;

ANGER; ANXIETY; ARTICLE; BLURRED VISION; CHEMOPROPHYLAXIS; CHOLESTASIS; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DIARRHEA; DIZZINESS; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG COST; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG INTERMITTENT THERAPY; DRUG MEGADOSE; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; FLUSHING; GASTROINTESTINAL SYMPTOM; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMATOLOGIC DISEASE; HUMAN; INSOMNIA; LEUKOPENIA; LOEFFLER PNEUMONIA; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; MEGALOBLASTIC ANEMIA; MENTAL DISEASE; MOOD CHANGE; NAUSEA; NEUROPATHY; NIGHTMARE; NONHUMAN; PATIENT COMPLIANCE; PERIPHERAL NEUROPATHY; PLASMODIUM FALCIPARUM; PLASMODIUM OVALE MALARIA; PLASMODIUM VIVAX MALARIA; PREGNANCY; PRURITUS; RETINOPATHY; SEIZURE; SIDE EFFECT; STEVENS JOHNSON SYNDROME; STOMATITIS; SYSTEMATIC REVIEW; TERATOGENICITY; THERAPY RESISTANCE; THROMBOCYTOPENIA; TINNITUS; UNSPECIFIED SIDE EFFECT;

ANTIMALARIALS; CHEMOPREVENTION; COSTS AND COST ANALYSIS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALARIA; MALE; PREGNANCY; TREATMENT OUTCOME;

EID: 79957555319     PISSN: 19957645     EISSN: 19957645     Source Type: Journal    
DOI: 10.1016/S1995-7645(11)60098-9     Document Type: Article

References (54)

1. World Health Organization World malaria report 2008. [Online] [Accessed on Sep. 15, 2009]. http://apps.who.int/malaria/wmr2008/.
2. Global Malaria Partnership Key malaria figures. [Online] [Accessed on Oct. 01,2009]. http://www.rollbackmalaria.org/keyfacts.html.
3. British Medical Association British national formulary 2009, British Medical Association, London.
4. Chen LH, Wilson ME, Schlagenhauf P Controversies and misconceptions in malaria chemoprophylaxis for travelers. JAMA 2007, 297:2251-2263.
5. Fitch CD Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs. Life Sci 2004, 74:1957-1972.
6. World Health Organization International travel and health 2009, WHO, Geneva.
7. Martin RE, Marchetti RV, Cowan AI, Howitt SM, Bröer S, Kirk K Chloroquine transport via the malaria parasite's chloroquine resistance transporter. Science 2009, 25:1680-1682.
8. Rieckmann KH, Davis DR, Hutton DC Plasmodium vivax resistance to chloroquine?. Lancet 1989, 2:1183-1184.
9. Mungthin M, Bray PG, Ridley RG, Ward SA Central role of hemoglobin degradation in mechanisms of action of 4-aminoquinolines, quinoline methanols, and phenanthrene methanols. Antimicrob Agents Chemother 1998, 42:2973-2977.
10. Kofoed K, Petersen E The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travelers from Denmark. J Travel Med 2003, 10:150-154.
11. Hopperus Buma AP, van Thiel PP, Lobel HO, Ohrt C, van Ameijden EJ, Veltink RL, et al. Long-term malaria chemoprophylaxis with mefloquine in Dutch marines in Cambodia. J Infect Dis 1996, 173:1506-1509.
12. Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 2004, 364:438-447.
13. Lorenz V, Karanis P Malaria vaccines: looking back and lessons learnt. Asian Pac J Trop Biomed 2011, 1(1):74-78.
14. Prabhu K, Murugan K, Nareshkumar A, Ramasubramanian N, Bragadeeswaran S Larvicidal and repellent potential of Moringa oleifera against malarial vector, Anopheles stephensi Liston (Insecta: Diptera: Culicidae). Asian Pac J Trop Biomed 2011, 1(2):124-129.
15. Krungkrai SR, Krungkrai J Malaria parasite carbonic anhydrase: inhibition of aromatic/heterocyclic sulfonamides and its therapeutic potential. Asian Pac J Trop Biomed 2011, 1(3):233-242.
16. Tewodros Zerihun, Abraham Degarege, Berhanu Erko Association of ABO blood group and Plasmodium falciparum malaria in Dore Bafeno Area, Southern Ethiopia. Asian Pac J Trop Biomed 2011, 1(4):289-294.
17. Ohrt C, Richie TL, Widjaja H, Shanks GD, Fitriadi J, Fryauff DJ, et al. Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1997, 126:963-972.
18. Sonmez A, Harlak A, Kilic S, Polat Z, Hayat L, Keskin O, et al. The efficacy and tolerability of doxycycline and mefloquine in malaria prophylaxis of the ISAF troops in Afghanistan. J Infect 2005, 51:253-258.
19. ter Kuile FO, van Eijk AM, Filler SJ Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. JAMA 2007, 297:2603-2616.
20. Gesase S, Gosling RD, Hashim R, Ord R, Naidoo I, Madebe R, et al. High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581. PLoS One 2009, 4:e4569.
21. Bell DJ, Nyirongo SK, Mukaka M, Zijlstra EE, Plowe CV, Molyneux ME, et al. Sulfadoxine-pyrimethamine-based combinations for malaria: a randomised blinded trial to compare efficacy, safety and selection of resistance in Malawi. PLoS One 2008, 3:e1578.
22. World Health Organization Report of the technical consultation on intermittent preventive treatment in infants (IPTi) 2009, WHO\HQ, Room D46025, Geneva.
23. Krause G, Schoneberg I, Altmann D, Stark K Chemoprophylaxis and malaria death rates. Emerg Infect Dis 2006, 12:447-451.
24. Nakato H, Vivancos R, Hunter PR A systematic review and meta-analysis of the effectiveness and safety of atovaquone proguanil (Malarone) for chemoprophylaxis against malaria. J Antimicrob Chemother 2007, 60:929-936.
25. Soto J, Toledo J, Luzz M, Gutierrez P, Berman J, Duparc S Randomized, double-blind, placebo-controlled study of Malarone for malaria prophylaxis in non-immune Colombian soldiers. Am J Trop Med Hyg 2006, 75:430-433.
26. Sutherland CJ, Laundy M, Price N, Burke M, Fivelman QL, Pasvol G, et al. Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil. Malar J 2008, 7:240.
27. Overbosch D, Schilthuis H, Bienzle U, Behrens RH, Kain KC, Clarke PD, et al. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study. Clin Infect Dis 2001, 33:1015-1021.
28. van Riemsdijk MM, Sturkenboom MC, Ditters JM, Ligthelm RJ, Overbosch D, Stricker BH Atovaquone plus chloroguanide versus mefloquine for malaria prophylaxis: a focus on neuropsychiatric adverse events. Clin Pharmacol Ther 2002, 72:294-301.
29. Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET, Magill AJ Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. Am J Trop Med Hyg 2006, 75:402-415.
30. Bryan JP Cost considerations of malaria chemoprophylaxis including use of primaquine for primary or terminal chemoprophylaxis. Am J Trop Med Hyg 2006, 75:416-420.
31. Carroll ID, Williams DC Pre-travel vaccination and medical prophylaxis in the pregnant traveler. Travel Med Infect Dis 2008, 6:259-275.
32. Soto J, Toledo J, Rodriquez M, Sanchez J, Herrera R, Padilla J, et al. Double-blind, randomized, placebo-controlled assessment of chloroquine/primaquine prophylaxis for malaria in nonimmune Colombian soldiers. Clin Infect Dis 1999, 29:199-201.
33. Soto J, Toledo J, Rodriquez M, Sanchez J, Herrera R, Padilla J, et al. Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998, 129:241-244.
34. Pages F, Boutin JP, Meynard JB, Keundjian A, Ryfer S, Giurato L, et al. Tolerability of doxycycline monohydrate salt vs. chloroquine-proguanil in malaria chemoprophylaxis. Trop Med Int Health 2002, 7:919-924.
35. Heppner DG, Walsh DS, Uthaimongkol N, Tang DB, Tulyayon S, Permpanich B, et al. Randomized, controlled, double-blind trial of daily oral azithromycin in adults for the prophylaxis of Plasmodium vivax malaria in Western Thailand. Am J Trop Med Hyg 2005, 73:842-849.
36. Anderson SL, Berman J, Kuschner R, Wesche D, Magill A, Wellde B, et al. Prophylaxis of Plasmodium falciparum malaria with azithromycin administered to volunteers. Ann Intern Med 1995, 123:771-773.
37. Taylor WR, Richie TL, Fryauff DJ, Picarima H, Ohrt C, Tang D, et al. Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia. Clin Infect Dis 1999, 28:74-81.
38. World Health Organization Regional Office for Africa A strategic framework for malaria prevention and control during pregnancy in the African region 2004, WHO, Brazzaville.
39. Bertin G, Ndam NT, Jafari-Guemouri S, Fievet N, Renart E, Sow S, et al. High prevalence of Plasmodium falciparum pfcrt K76T mutation in pregnant women taking chloroquine prophylaxis in Senegal. J Antimicrob Chemother 2005, 55:788-791.
40. Salihu HM, Tchuinguem G, Ratard R Effect of chloroquine prophylaxis on birthweight and malaria parasite load among pregnant women delivering in a regional hospital in Cameroon. West Indian Med J 2000, 49:143-147.
41. Salihu HM, Naik EG, Tchuinguem G, Bosny JP, Dagne G Weekly chloroquine prophylaxis and the effect on maternal haemoglobin status at delivery. Trop Med Int Health 2002, 7:29-34.
42. Ndyomugyenyi R, Magnussen P Chloroquine prophylaxis, iron-folic acid supplementation or case management of malaria attacks in primigravidae in western Uganda: effects on maternal parasitaemia and haemoglobin levels and on birthweight. Trans R Soc Trop Med Hyg 2000, 94:413-418.
43. Villegas L, McGready R, Htway M, Paw MK, Pimanpanarak M, Arunjerdja R, et al. Chloroquine prophylaxis against vivax malaria in pregnancy: a randomized, double-blind, placebo-controlled trial. Trop Med Int Health 2007, 12:209-218.
44. Nosten F, Karbwang J, White NJ, Honeymoon, Na Bangchang K, Bunnag D, et al. Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study. Br J Clin Pharmacol 1990, 30:79-85.
45. Palmer KJ, Holliday SM, Brogden RN Mefloquine: A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1993, 45:430-475.
46. Schultz LJ, Steketee RW, Macheso A, Kazembe P, Chitsulo L, Wirima JJ The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg 1994, 51:515-522.
47. Mayor A, Serra-Casas E, Sanz S, Aponte JJ, Macete E, Mandomando I, et al. Molecular markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment for malaria in Mozambican infants. J Infect Dis 2008, 197:1737-1742.
48. Iyer JK, Milhous WK, Cortese JF, Kublin JG, Plowe CV Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine. Lancet 2001, 358:1066-1067.
49. Dunne MW, Singh N, Shukla M, Valecha N, Bhattacharyya PC, Dev V, et al. A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India. J Infect Dis 2005, 191:1582-1588.
50. Lewis D, Mulenga M, Oduro A, Mugyenyi P, Wasunna M, Kokwaro GO, et al. Phase 2/3, randomized, double blind, comparative trial of azithromycin plus chloroquine versus mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in Africa. 5th European Congress on Tropical Medicine and International Health Amsterdam, 2007. Amsterdam; 2007.
51. Chico RM, Pittrof R, Greenwood B, Chandramohan D Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy. Malar J 2008, 7:255-269.
52. Behrens RH, Bisoffi Z, Bjorkman A, Gascon J, Hatz C, Jelinek T, et al. Malaria prophylaxis policy for travellers from Europe to the Indian Subcontinent. Malar J 2006, 5:7.
53. Van Herck K, Van Damme P, Castelli F, Zuckerman J, Nothdurft H, Dahlgren AL, et al. Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey. J Travel Med 2004, 11:3-8.
54. Center for Disease Control Travelers health - malaria. [Online] [Accessed on Dec 14, 2009]. http://www.nc.cdc.gov/travel/yellowbook/2010/chapter-2/malaria.aspx.